Publication

Byline

Parking dispute, power struggle: How Tiwari and Shukla families in Lucknow turned on each other

LUCKNOW, Oct. 27 -- Just 10 metres separate the homes of the Tiwari and Shukla families in Saadatganj, but a bloodbath allegedly sparked by a parking dispute and a battle for local dominance has left ... और पढ़ें


Karnataka SIR: Final electoral roll records 4.55 crore voters, net count falls by 99.32 lakh

Bengaluru, Oct. 27 -- Karnataka's electorate has declined by 99.32 lakh following the Special Intensive Revision (SIR), with the final electoral roll published on Tuesday listing 4.55 crore electors, ... और पढ़ें


Who is Akshit Choudhary? Indian Overseas Bank names new CFO; Check his qualifications and previous roles

New Delhi, Oct. 27 -- Indian Overseas Bank (IOB) has appointed Akshit Choudhary, currently a general manager at the public sector lender, as its new chief financial officer (CFO), replacing Madhaw Cha... और पढ़ें


India vs New Zealand 3rd T20I 2026 Winner And Toss Prediction: Who Will Win Today's Match? Check Captain, Vice-Captain Choices And More

India, Oct. 27 -- India will look to wrap up the five-match T20I series against New Zealand when the two sides meet in the third game at Hnry Stadium, also known as Sky Stadium, in Wellington on Tuesd... और पढ़ें


Singapore Clinical Trial: A Phase 2, Randomized, Open-Label Dose Optimization and Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of Tersolisib (LY4064809) Combined with a CDK4/6 Inhibitor and Endocrine Therapy in Adults with HR+, HER2- Advanced Breast Cancer with a PIK3CA Mutation Who Received No Prior Treatment for Advanced Breast Cancer (PIKALO-2)

Singapore, Oct. 27 -- The Health Sciences Authority received information related to the study titled 'A Phase 2, Randomized, Open-Label Dose Optimization and Phase 3, Randomized, Double-Blind, Placebo... और पढ़ें


Singapore Clinical Trial: A Phase 1 Open-Label Study to Determine the Effect of Injection Site on the Relative Bioavailability of a Single Subcutaneous Dose of LY3841136 and to Evaluate the Pharmacokinetics of a Single Intravenous Dose of LY3841136 in Healthy Participants.

Singapore, Oct. 27 -- The Health Sciences Authority received information related to the study titled 'A Phase 1 Open-Label Study to Determine the Effect of Injection Site on the Relative Bioavailabili... और पढ़ें


Singapore Clinical Trial: A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Ensifentrine (MK-5884) Versus Placebo for the Prevention of COPD Exacerbations in Adults with a History of Moderate or Severe Exacerbations While Receiving Standard of Care (ENHANCE-3)

Singapore, Oct. 27 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety ... और पढ़ें


Singapore Clinical Trial: A Phase 1, Randomized, Placebo-Controlled, Single and Multiple Ascending Dose-Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LY4174794 in Participants with Obesity or Overweight who are Otherwise Healthy

Singapore, Oct. 27 -- The Health Sciences Authority received information related to the study titled 'A Phase 1, Randomized, Placebo-Controlled, Single and Multiple Ascending Dose-Escalation Study to ... और पढ़ें


Singapore Clinical Trial: A Phase 2 Platform Basket Study Evaluating Advanced Therapies in Subjects with Moderately to Severely Active Crohn's Disease or Ulcerative Colitis

Singapore, Oct. 27 -- The Health Sciences Authority received information related to the study titled 'A Phase 2 Platform Basket Study Evaluating Advanced Therapies in Subjects with Moderately to Sever... और पढ़ें


Singapore Clinical Trial: A Phase 3, Randomized, Open-Label Study of Rinzimetostat (ORIC-944) in Combination with Darolutamide Compared with ARPI or Docetaxel in Patients with Metastatic Castration Resistant Prostate Cancer Previously Treated with Abiraterone Acetate (Himalayas-1)

Singapore, Oct. 27 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Randomized, Open-Label Study of Rinzimetostat (ORIC-944) in Combination with Darolutami... और पढ़ें